These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21356368)

  • 21. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
    Keane MP; Belperio JA; Arenberg DA; Burdick MD; Xu ZJ; Xue YY; Strieter RM
    J Immunol; 1999 Nov; 163(10):5686-92. PubMed ID: 10553099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis.
    Segawa S; Goto D; Iizuka A; Kaneko S; Yokosawa M; Kondo Y; Matsumoto I; Sumida T
    Clin Exp Immunol; 2016 Sep; 185(3):348-60. PubMed ID: 27083148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice.
    Izbicki G; Or R; Christensen TG; Segel MJ; Fine A; Goldstein RH; Breuer R
    Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1110-6. PubMed ID: 12376365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A-producing γδ T cells promote liver pathology in acute murine schistosomiasis.
    Sun L; Gong W; Shen Y; Liang L; Zhang X; Li T; Chen TT; Hu Y; Cao J
    Parasit Vectors; 2020 Jul; 13(1):334. PubMed ID: 32611373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
    Chen ES; Greenlee BM; Wills-Karp M; Moller DR
    Am J Respir Cell Mol Biol; 2001 May; 24(5):545-55. PubMed ID: 11350823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photobiomodulation therapy improves both inflammatory and fibrotic parameters in experimental model of lung fibrosis in mice.
    Brochetti RA; Leal MP; Rodrigues R; da Palma RK; de Oliveira LVF; Horliana ACRT; Damazo AS; de Oliveira APL; Paula Vieira R; Lino-Dos-Santos-Franco A
    Lasers Med Sci; 2017 Nov; 32(8):1825-1834. PubMed ID: 28712048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
    Jiang D; Liang J; Hodge J; Lu B; Zhu Z; Yu S; Fan J; Gao Y; Yin Z; Homer R; Gerard C; Noble PW
    J Clin Invest; 2004 Jul; 114(2):291-9. PubMed ID: 15254596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
    J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture.
    Chen X; Sun R; Hu J; Mo Z; Yang Z; Liao D; Zhong N
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):278-86. PubMed ID: 18684219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
    Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice.
    Lei Y; Wang K; Li X; Li Y; Feng X; Zhou J; Zhang Z; Huang C; Zhang T
    Clin Sci (Lond); 2019 Apr; 133(7):789-804. PubMed ID: 30902828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of bleomycin-induced lung fibrosis in CD28-deficient mice.
    Okazaki T; Nakao A; Nakano H; Takahashi F; Takahashi K; Shimozato O; Takeda K; Yagita H; Okumura K
    J Immunol; 2001 Aug; 167(4):1977-81. PubMed ID: 11489978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
    De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
    Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
    Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
    Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.
    Ortiz LA; Lasky J; Hamilton RF; Holian A; Hoyle GW; Banks W; Peschon JJ; Brody AR; Lungarella G; Friedman M
    Exp Lung Res; 1998; 24(6):721-43. PubMed ID: 9839161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.